Imatinib

Inquiry

For Research Use Only.

Size	Price	Stock	Quantity
10 g	$249	In stock

Category

Impurities

Cat.No.

NP3277

CAS

152459-95-5

Product Name

Imatinib

Structure

Product Details

Description

Imatinib inhibits the SLF-dependent activation of wild-type c-kit kinase activity with an IC50 for these effects of approximately 0.1 μM, which is similar to the concentration required for inhibition of PDGFR. Imatinib is an oral chemotherapy agent used to treat cancers. Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+), certain types of gastrointestinal stromal tumors (GIST), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), systemic mastocytosis, and myelodysplastic syndrome.

Synonyms

CGP057148B; STI571; Gleevec; Glivec; N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; 4-[(4-Methyl-1-piperazinyl)methyl]-N-(4-methyl-3-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}phenyl)benzamide

IUPAC Name

4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide

Molecular Weight

493.60

Molecular Formula

C29H31N7O

Canonical SMILES

CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5

InChI

InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)

InChIKey

KTUFNOKKBVMGRW-UHFFFAOYSA-N

Boiling Point

451°C

Melting Point

207-209°C

Flash Point

196°C

Purity

>98%

Density

1.3±0.1 g/cm3

Solubility

Soluble in DMSO (Slightly, Heated), Methanol (Slightly, Heated)

Appearance

White to Off-white Solid

Storage

Store at -20°C

Form

Powder

Packaging

10 g

Vapor Pressure

6.03E-24mmHg at 25°C

Products

Inquiry

* Name:
* Phone:
* Quantity
* Email:
* Service & Products of Interested: [Impurities] Imatinib (NP3277)
Project Description:
* Verification Code:
SUBMIT